Literature DB >> 3938680

Mitomycin C in advanced breast cancer.

L Lenaz.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3938680     DOI: 10.1016/0305-7372(85)90007-6

Source DB:  PubMed          Journal:  Cancer Treat Rev        ISSN: 0305-7372            Impact factor:   12.111


× No keyword cloud information.
  7 in total

1.  Modulation of mitomycin C-induced multidrug resistance in vitro.

Authors:  R T Dorr; J D Liddil
Journal:  Cancer Chemother Pharmacol       Date:  1991       Impact factor: 3.333

2.  Effect of selective inhibition of aquaporin 1 on chemotherapy sensitivity of J82 human bladder cancer cells.

Authors:  Xuefeng Zhang; Yun Chen; Liming Dong; Benkang Shi
Journal:  Oncol Lett       Date:  2018-01-04       Impact factor: 2.967

Review 3.  Cardiotoxicity of chemotherapeutic agents: incidence, treatment and prevention.

Authors:  V B Pai; M C Nahata
Journal:  Drug Saf       Date:  2000-04       Impact factor: 5.606

4.  Ifosfamide + mitoxantrone in advanced breast cancer previously treated with anthracyclines.

Authors:  J Bellmunt; S Morales; M Navarro; L A Solé
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

5.  Repair of mitomycin C mono- and interstrand cross-linked DNA adducts by UvrABC: a new model.

Authors:  Mao-wen Weng; Yi Zheng; Vijay P Jasti; Elise Champeil; Maria Tomasz; Yinsheng Wang; Ashis K Basu; Moon-shong Tang
Journal:  Nucleic Acids Res       Date:  2010-07-06       Impact factor: 16.971

6.  The role of NAD(P)H:quinone oxidoreductase in mitomycin C- and porfiromycin-resistant HCT 116 human colon-cancer cells.

Authors:  S S Pan; S A Akman; G L Forrest; C Hipsher; R Johnson
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

7.  Mechanism of differential sensitivity of human bladder cancer cells to mitomycin C and its analogue.

Authors:  B H Xu; V Gupta; S V Singh
Journal:  Br J Cancer       Date:  1994-02       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.